GeneDx Holdings Corp.
WGS· Nasdaq
WGSGeneDx Holdings Corp.
Filed Jul 21, 2021 · 10-Q · 21 days after period end · 0001213900-21-037929
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Revenue | $47.02M | $30.10M |
| Net Income | -$46.16M | -$32.05M |
| EPS Diluted | -$41.94 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Jul 21, 2021 · 21 d after period end
